SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about amendments to memorandum and articles of association

13 Dec 2022 Evaluate
Zim Laboratories has informed that the Capital Clause i.e., Clause V of the Company's Memorandum of Association (MOA) has been amended, vide Ordinary Resolution passed by the Members in the Extraordinary General Meeting (EGM) of the Company held on Monday, 12th December, 2022. Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, details of amendment are mentioned as follows: ‘V. The Authorised Share Capital of the Company is Rs 75,00,00,000 divided into 7,50,00,000 Equity shares of Rs 10 each’.

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×